Concepedia

Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection

Harika Öykü Dinç, Neşe Saltoğlu, Günay Can, İ̇lker İnanç Balkan, Beyhan Budak, Doğukan Özbey, Bilge Çağlar, Rıdvan Karaali, Bilgül Mete, Yeşim Tok,

Vaccine · 2021 · 47 citations · 12 references

DOIFull text

Open access

Concepts

References

12

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao, Linlin Bao, Haiyan Mao et al. · Science · 2020 · 1.5K citations · Full text

, , +15

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · The Lancet Infectious Diseases · 2020 · 1.5K citations · Full text

, , +17

The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries

Patrick Walker, Charles Whittaker, Oliver J. Watson et al. · Science · 2020 · 1.1K citations · Full text

, , +16

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)

Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker et al. · Clinical Infectious Diseases · 2020 · 1.1K citations · Full text

, , +12

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers

Sheila Lumley, Denise O’Donnell, Nicole Stoesser et al. · New England Journal of Medicine · 2020 · 1K citations · Full text

, , +16